Patents by Inventor Maurice Bordoni

Maurice Bordoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Radioactive tagged compounds and method for the treatment of metastatic bone cancer
    Patent number: 5006329
    Abstract: Organophosphonates such as methylene diphosphonates and analogs thereof are tagged with chromium-51 for the treatment of bone cancer without causing damage to bone marrow. The chromium-51 organophosphonates seek out, attach to, and treat bone tumors with high specificity.
    Type: Grant
    Filed: January 26, 1989
    Date of Patent: April 9, 1991
    Assignee: Cadema Medical Products, Inc.
    Inventors: Ephraim Lieberman, Maurice Bordoni, Alfred Thornton
  • Treatment of arthritis, including rheumatoid arthritis with .sup.166 Holmium radionuclide
    Patent number: 4849209
    Abstract: .sup.1/3 Holmium in a carrier metallic hydroxide aggregate is disclosed for the treatment of arthritis and, in particular, rheumatoid arthritis. The compound disclosed preferably has a particle size of 1 to 40 microns, Beta energy emissions in the range of 1.76-1.84 MeV, low levels of gamma ray emissions and a radioactive half-life of 26.8 hours. The preferred metallic hydroxide is selected from the group consisting of Ferric Hydroxide, Aluminum Hydroxide, Bismuth Hydroxide, Chromium Hydroxide, Cupric Hydroxide, Manganese Hydroxide and Stannous Hydroxide. Methods are also disclosed for the preparation of the compound, as well as for the methods of its administration to a patient in need thereof.
    Type: Grant
    Filed: January 28, 1987
    Date of Patent: July 18, 1989
    Assignee: Cadema Medical Products, Inc.
    Inventors: Ephraim Lieberman, Maurice Bordoni, Alfred Thornton